Investment House LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 129.5% during the third quarter, HoldingsChannel reports. The firm owned 69,385 shares of the healthcare conglomerate’s stock after acquiring an additional 39,149 shares during the quarter. UnitedHealth Group makes up 1.1% of Investment House LLC’s investment portfolio, making the stock its 23rd largest position. Investment House LLC’s holdings in UnitedHealth Group were worth $23,959,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC lifted its stake in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC boosted its stake in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after acquiring an additional 2,324 shares during the period. McAdam LLC raised its stake in UnitedHealth Group by 12.7% in the 2nd quarter. McAdam LLC now owns 1,135 shares of the healthcare conglomerate’s stock valued at $354,000 after acquiring an additional 128 shares during the period. CMT Capital Markets Trading GmbH bought a new position in UnitedHealth Group during the second quarter worth $340,000. Finally, Strategic Investment Solutions Inc. IL bought a new position in shares of UnitedHealth Group in the second quarter valued at about $62,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
Analyst Ratings Changes
Several research analysts have weighed in on UNH shares. Mizuho increased their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. JPMorgan Chase & Co. lifted their price target on UnitedHealth Group from $310.00 to $425.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Weiss Ratings reiterated a “hold (c-)” rating on shares of UnitedHealth Group in a research report on Wednesday. Deutsche Bank Aktiengesellschaft downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target on the stock. in a research note on Wednesday, October 29th. Finally, TD Cowen boosted their price objective on shares of UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a report on Thursday, October 30th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $386.33.
UnitedHealth Group Price Performance
Shares of NYSE:UNH opened at $356.46 on Friday. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $322.89 billion, a PE ratio of 18.60, a PEG ratio of 2.15 and a beta of 0.42. The firm has a 50 day moving average of $332.07 and a 200-day moving average of $323.44. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company’s revenue was up 12.2% on a year-over-year basis. During the same period in the previous year, the business earned $7.15 earnings per share. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th were given a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Monday, December 8th. UnitedHealth Group’s payout ratio is currently 46.14%.
Key UnitedHealth Group News
Here are the key news stories impacting UnitedHealth Group this week:
- Positive Sentiment: Mizuho reiterated a Buy on UNH and kept a $430 price target, highlighting the importance of the upcoming Medicare Advantage 2027 Advance Notice as a potential tailwind for enrollment and margins. Mizuho reiterates Buy
- Positive Sentiment: Retail sentiment on Reddit and X has moved from deeply bearish to neutral over the past week, helping shares recover after retail-driven selling earlier this month. Reddit sentiment shift
- Neutral Sentiment: Morgan Stanley trimmed its price target slightly (from $411 to $409) but kept an Overweight rating, signaling continued analyst confidence despite a small technical cut to the target. Morgan Stanley target change
- Neutral Sentiment: Recent commentary and market moves note UNH has outperformed the broader market in short-term trading, reflecting mixed buying interest ahead of the Jan. 27 catalyst. Outperforms broader market
- Negative Sentiment: UnitedHealth executives faced tough questioning from Congress on healthcare affordability β a reminder of political/regulatory risk that could pressure policy outcomes or public perception. Congressional grilling
- Negative Sentiment: UnitedHealth announced it will rebate 2026 ACA plan profits to customers, which could weigh on near-term margins and highlights ongoing regulatory/competitive pressure in the individual market. ACA profit rebate
- Negative Sentiment: Analysts warn of rising medical costs and a higher medical cost ratio (MCR) heading into Q4 results β several pieces advise caution until the Jan. 27 release when clearer margin and cost detail will arrive. Cost pressures warning
UnitedHealth Group Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
Further Reading
- Five stocks we like better than UnitedHealth Group
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- Your Signature Is Missing β Act Before Itβs Too Late
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
